Quest Diagnostics Inc vs KraneShares Hang Seng TECH Index ETF — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while KraneShares Hang Seng TECH Index ETF trades at $13.5. The key difference: Quest Diagnostics Inc pays a 1.45% dividend while KraneShares Hang Seng TECH Index ETF pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, KraneShares Hang Seng TECH Index ETF nearer its low. Which is the better fit depends on your goals.
| DGX | KTEC | |
|---|---|---|
Market Cap | $26.21B | — |
Sector | Health | Sector/Thematic |
52-Week High | $238.50 | $19.51 |
52-Week Low | $173.49 | $12.00 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →